Rapport
Harm reduction in Europe: coverage and civil society advocacy
Auteur(s) :
EuroHRN (European Harm Reduction network) ;
STOICESCU, C. ;
COOK, C.
Année :
2011
Page(s) :
53 p.
Langue(s) :
Anglais
Éditeur(s) :
EuroHRN - European Harm Reduction network
Domaine :
Drogues illicites / Illicit drugs
Thésaurus géographique
EUROPE
;
EUROPE DE L'EST
;
EUROPE DE L'OUEST
Thésaurus mots-clés
REDUCTION DES RISQUES ET DES DOMMAGES
;
EPIDEMIOLOGIE
;
INTERVENTION
;
GEOGRAPHIE
;
MORBIDITE
;
POLITIQUE
;
ECHANGE DE SERINGUES
;
TRAITEMENT DE MAINTENANCE
;
PRISON
;
STRUCTURE DE PROXIMITE
;
MILIEU FESTIF
Résumé :
This report presents the findings of the EuroHRN civil society audit, an activity aimed at collating existing epidemiological and service coverage data and consulting with experts in order to map key issues for harm reduction in Europe.
This includes coverage of harm reduction interventions, policies and civil society advocacy priorities.
A complementary questionnaire was disseminated to focal points in each EuroHRN member country to understand the barriers to accessing these services at the national and local levels.
This activity aims to provide a snapshot of the current state of harm reduction across the region, provide a baseline for EuroHRN and civil society in the region and act as a regional advocacy and planning tool.
STRUCTURE OF THE REPORT:
Section 1 provides a brief introduction to the EuroHRN and to the information presented in this report.
Section 2 comprises four parts. The first two, Drug use and Drug-related harms, provide a general overview of the most recent data on drug use trends and selected drug-related harms in the region. The third part summarises findings on harm reduction coverage, barriers to service access and scale up across the region, as well as emerging advocacy issues for Europe. Finally, advocacy priorities for civil society emerging out of this exercise are presented for Europe and for the three subregions.
Section 3 presents region- and country-specific findings for each of the sub-regions covered by the EuroHRN: Eastern Europe, North Europe and South Europe. Within each sub-regional chapter, text boxes highlight relevant emerging issues and innovative harm reduction practices in the region.
This includes coverage of harm reduction interventions, policies and civil society advocacy priorities.
A complementary questionnaire was disseminated to focal points in each EuroHRN member country to understand the barriers to accessing these services at the national and local levels.
This activity aims to provide a snapshot of the current state of harm reduction across the region, provide a baseline for EuroHRN and civil society in the region and act as a regional advocacy and planning tool.
STRUCTURE OF THE REPORT:
Section 1 provides a brief introduction to the EuroHRN and to the information presented in this report.
Section 2 comprises four parts. The first two, Drug use and Drug-related harms, provide a general overview of the most recent data on drug use trends and selected drug-related harms in the region. The third part summarises findings on harm reduction coverage, barriers to service access and scale up across the region, as well as emerging advocacy issues for Europe. Finally, advocacy priorities for civil society emerging out of this exercise are presented for Europe and for the three subregions.
Section 3 presents region- and country-specific findings for each of the sub-regions covered by the EuroHRN: Eastern Europe, North Europe and South Europe. Within each sub-regional chapter, text boxes highlight relevant emerging issues and innovative harm reduction practices in the region.